» Articles » PMID: 23348567

IF1 Limits the Apoptotic-signalling Cascade by Preventing Mitochondrial Remodelling

Overview
Specialty Cell Biology
Date 2013 Jan 26
PMID 23348567
Citations 47
Authors
Affiliations
Soon will be listed here.
Abstract

Mitochondrial structure has a central role both in energy conversion and in the regulation of cell death. We have previously shown that IF1 protects cells from necrotic cell death and supports cristae structure by promoting the oligomerisation of the F1Fo-ATPsynthase. As IF1 is upregulated in a large proportion of human cancers, we have here explored its contribution to the progression of apoptosis and report that an increased expression of IF1, relative to the F1Fo-ATPsynthase, protects cells from apoptotic death. We show that IF1 expression serves as a checkpoint for the release of Cytochrome c (Cyt c) and hence the completion of the apoptotic program. We show that the progression of apoptosis engages an amplification pathway mediated by: (i) Cyt c-dependent release of ER Ca(2+), (ii) Ca(2+)-dependent recruitment of the GTPase Dynamin-related protein 1 (Drp1), (iii) Bax insertion into the outer mitochondrial membrane and (iv) further release of Cyt c. This pathway is accelerated by suppression of IF1 and delayed by its overexpression. IF1 overexpression is associated with the preservation of mitochondrial morphology and ultrastructure, consistent with a central role for IF1 as a determinant of the inner membrane architecture and with the role of mitochondrial ultrastructure in the regulation of Cyt c release. These data suggest that IF1 is an antiapoptotic and potentially tumorigenic factor and may be a valuable predictor of responsiveness to chemotherapy.

Citing Articles

Mitochondrial protein deacetylation by SIRT3 in osteoclasts promotes bone resorption with aging in female mice.

Richardson K, Adam G, Ling W, Warren A, Marques-Carvalho A, Thostenson J Mol Metab. 2024; 88:102012.

PMID: 39154858 PMC: 11399565. DOI: 10.1016/j.molmet.2024.102012.


Peptides Targeting the IF1-ATP Synthase Complex Modulate the Permeability Transition Pore in Cancer HeLa Cells.

Grandi M, Fabbian S, Solaini G, Baracca A, Bellanda M, Giorgio V Int J Mol Sci. 2024; 25(9).

PMID: 38731874 PMC: 11083241. DOI: 10.3390/ijms25094655.


The Pro-Oncogenic Protein IF Promotes Proliferation of Anoxic Cancer Cells during Re-Oxygenation.

Righetti R, Grillini S, Del Dotto V, Costanzini A, Liuzzi F, Zanna C Int J Mol Sci. 2023; 24(19).

PMID: 37834071 PMC: 10572598. DOI: 10.3390/ijms241914624.


The Mitochondrial ATP Synthase/IF1 Axis in Cancer Progression: Targets for Therapeutic Intervention.

Dominguez-Zorita S, Cuezva J Cancers (Basel). 2023; 15(15).

PMID: 37568591 PMC: 10417293. DOI: 10.3390/cancers15153775.


IF1 ablation prevents ATP synthase oligomerization, enhances mitochondrial ATP turnover and promotes an adenosine-mediated pro-inflammatory phenotype.

Dominguez-Zorita S, Romero-Carraminana I, Santacatterina F, Esparza-Molto P, Simo C, Del-Arco A Cell Death Dis. 2023; 14(7):413.

PMID: 37433784 PMC: 10336053. DOI: 10.1038/s41419-023-05957-z.


References
1.
Frezza C, Cipolat S, Martins de Brito O, Micaroni M, Beznoussenko G, Rudka T . OPA1 controls apoptotic cristae remodeling independently from mitochondrial fusion. Cell. 2006; 126(1):177-89. DOI: 10.1016/j.cell.2006.06.025. View

2.
Otera H, Mihara K . Mitochondrial dynamics: functional link with apoptosis. Int J Cell Biol. 2012; 2012:821676. PMC: 3320010. DOI: 10.1155/2012/821676. View

3.
James D, Parone P, Mattenberger Y, Martinou J . hFis1, a novel component of the mammalian mitochondrial fission machinery. J Biol Chem. 2003; 278(38):36373-9. DOI: 10.1074/jbc.M303758200. View

4.
Strasser A, OConnor L, Dixit V . Apoptosis signaling. Annu Rev Biochem. 2000; 69:217-45. DOI: 10.1146/annurev.biochem.69.1.217. View

5.
Baumgartner H, Gerasimenko J, Thorne C, Ferdek P, Pozzan T, Tepikin A . Calcium elevation in mitochondria is the main Ca2+ requirement for mitochondrial permeability transition pore (mPTP) opening. J Biol Chem. 2009; 284(31):20796-803. PMC: 2742844. DOI: 10.1074/jbc.M109.025353. View